Dear Women's Imaging Insider,
Nuclear breast imaging refers to everything from PET and positron emission mammography (PEM) to breast-specific gamma imaging (BSGI) and molecular breast imaging (MBI). The technology shows physiological changes that are usually indicators of cancer and that are detectable earlier than those identified by other imaging modalities.
So is nuclear breast imaging poised to become a mainstream breast cancer screening and diagnosis tool?
The answer is a qualified yes, according to a presentation given at the recent National Consortium of Breast Centers (NCBC) annual meeting in Las Vegas. Click here to read what Dr. Michael Linver of X-Ray Associates of New Mexico had to say about the future of nuclear breast imaging, particularly PEM.
Once you've read our Insider Exclusive, take a look at what else is going on in the Women's Imaging Digital Community:
- Read why Emory University researchers believe that the potential for lower radiation dose could turn DBT into a breast screening tool.
- Discover why FDG-PET/CT is useful for predicting the survival of breast cancer patients with hepatic metastases.
- Find out whether breast density notification laws are cause for celebration.
- Read why it's so important for breast centers to track their quality.
- Learn how politics may be blocking widespread use of breast MRI for implants.
As always, if you have a comment, report, or article idea to share about any aspect of women's imaging, I invite you to contact me.
